Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0378-3950

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0378-3950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Chemical structure diagram of atorvastatin calcium showing the molecular arrangement with calcium ions and water molecules indicated.*

FDA Label Image

Atorvastatin Calcium Tablets 10 mg Bottle Label (Image 02)

Packaging label for Atorvastatin Calcium 10 mg film-coated tablets by Mylan Pharmaceuticals Inc., containing 90 tablets. The label includes dosage strength, tablet imprint, storage instructions, barcode, and reminder that the product is Rx only.*

FDA Label Image

Atorvastatin Calcium Tablets 20 mg Bottle Label (Image 03)

Label for Atorvastatin Calcium Tablets, USP 20 mg, film-coated oral tablets by Mylan Pharmaceuticals Inc. The label displays the NDC number 0378-3951-77, shows a tablet imprint '20', and indicates a package size of 90 tablets. It includes storage instructions, a barcode, and mentions the product is Rx only.*

FDA Label Image

Atorvastatin Calcium Tablets 40 mg Bottle Label (Image 04)

Label for Atorvastatin Calcium 40 mg film-coated tablets, USP, manufactured by Mylan Pharmaceuticals Inc. The label shows the tablet strength as 40 mg, with 90 tablets per container. It includes storage instructions, barcode, NDC 0378-3952-77, and usage notes indicating Rx only. The tablets are oval and marked with '40'.*

FDA Label Image

Atorvastatin Calcium Tablets 80 mg Bottle Label (Image 05)

Atorvastatin Calcium 80 mg film-coated tablets label for oral use by Mylan Pharmaceuticals Inc. The label includes the NDC 0378-3953-77, a depiction of two tablets marked "80", and specifies 90 tablets per container. It notes storage conditions, child-resistant packaging instructions, and information about the manufacturer in Morgantown, WV, USA with tablets made in India.*

FDA Label Image

Image 06

A line graph comparing cumulative incidence (%) over 3.5 years between atorvastatin and placebo. The x-axis represents time in years, and the y-axis represents cumulative incidence percentage. The graph includes a hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Image 07

A line graph comparing the cumulative hazard percentage over time (up to 5 years) between Atorvastatin and placebo groups. The x-axis represents years of follow-up to the first primary endpoint, and the y-axis shows cumulative hazard percentage. Atorvastatin group shows a consistently lower cumulative hazard than placebo, with hazard ratio and p-value indicated.*

FDA Label Image

Image 08

A line graph comparing the percentage of subjects experiencing an event over a five-year period for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to the first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value statistics indicating a comparative analysis between the two dosage groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.